Benzinga  Aug 20  Comment 
Macrocure Ltd (NASDAQ: MCUR) shares dropped 74.51 percent to $3.07. Macrocure reported that its Phase III clinical trial of CureXcell in venous leg ulcers is not expected to meet primary endpoint. Oppenheimer downgraded Macrocure from Outperform...  Aug 20  Comment 
Investors are bracing for a bruising session Thursday.
Benzinga  Jun 26  Comment 
LifePoint Health Inc (NASDAQ: LPNT) shares gained 2.04 percent to reach a new 52-week high of $85.10. Mizuho Securities upgraded LifePoint Health from Neutral to Buy. Kirkland's, Inc. (NASDAQ: KIRK) shares touched a new 52-week high of...
Benzinga  May 21  Comment 
Shares of Kirkland's, Inc. (NASDAQ: KIRK) gained more than 3 percent in pre-market trading after the company reported stronger-than-expected earnings for the fiscal first quarter on Thursday. The Brentwood, Tennessee-based company posted...
Benzinga  Mar 27  Comment 
Analysts at EVA Dimensions upgraded Kirkland's Inc. (NASDAQ: KIRK) from Sell to Overweight. Kirkland's shares have gained 23.92% over the past 52 weeks, while the S&P 500 index has surged 10.69% in the same period. Kirkland's shares dropped...
Benzinga  Mar 12  Comment 
Kirkland's Inc. (NASDAQ: KIRK) reported in-line earnings for the fiscal fourth quarter on Thursday. The Brentwood, Tennessee-based company posted a quarterly profit of $15.6 million, or $0.87 per share, up from $12.3 million, or $0.69 per share,...
Benzinga  Jan 20  Comment 
In a report published Tuesday, Barrington Research analyst Kristine Koerber reiterated an Outperform rating on Kirkland's, Inc. (NASDAQ: KIRK), and raised the price target from $24.00 to $28.00. In the report, Barrington Research noted, “We...

There is currently no text in this page, you can search for this page title in other pages or edit this page.
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki